Warthausen, Germany

Henri Doods

This inventor holds 76 USPTO granted patents and 14 published patent applications, plus 6 CIPO patents and 29 EPO patents, primarily in CGRP Antagonists (CPC class C07D). Top assignees: Boehringer Ingelheim International Gmbh, Dr. Karl Thomae Gmbh, Centrexion Therapeutics Corporation. Active years: 1991-2025.

USPTO Granted Patents = 76 

% Patents Active = 88.2

 

 

Average Co-Inventor Count = 7.4

ph-index = 11

Forward Citations = 576(Granted Patents)

Forward Citations (Not Self Cited) = 475(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Wathausen, DE (1991)
  • Warthausen, NL (2014 - 2015)
  • Ingelheim Am Rhein, DE (2019 - 2020)
  • Warthausen, DE (1991 - 2023)

Company Filing History:


Years Active: 1991-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
CGRP Antagonists
Somatostatin Agonists
Anti-Inflammatory Agents
B1-Receptor Antagonists
Pyrimidine Derivatives
Aryl Sulfonamides
Tetrahydrofuranyl Compounds
1H-Benzimidazole
Microsomal Prostaglandin E2 Synthase
Disubstituted Compounds
Cyano-Dimethyl-Methyl-Isoxazoles
Thiadiazoles
76 patents (USPTO):Explore Patents

Dear visitor, I have crafted an article about the innovative inventor Henri Doods, who stands as a beacon of inspiration in the world of inventions.

**Title: Henri Doods - A Trailblazer in the World of Inventions**

Introduction:

Henri Doods, a visionary inventor hailing from Warthausen, DE, is celebrated for his bold thinking and unwavering commitment to excellence in the realm of inventions.

Latest Patents:

Doods’ latest patents revolve around the groundbreaking (Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles. These inventions focus on their use as CB2 cannabinoid receptor agonists, offering novel pharmaceutical compositions for the treatment of CB2 receptor mediated disorders or conditions.

Career Highlights:

With an impressive portfolio of 75 patents, Doods has consistently pushed the envelope of innovation. He has contributed significantly to the field, with each invention showcasing his dedication to pioneering advancements.

Collaborations:

Throughout his illustrious career, Doods has collaborated with esteemed companies such as Boehringer Ingelheim International GmbH and Dr. Karl Thomae GmbH. His work alongside notable coworkers like Klaus Rudolf and Stephan Georg Mueller has further solidified his reputation as a trailblazer.

Conclusion:

Henri Doods’ remarkable journey as an inventor serves as a testament to the power of passion, dedication, and visionary thinking in driving innovation forward. His legacy will continue to inspire future generations of inventors to dream big and make a lasting impact on the world of inventions.

If you have any more specific requests or need further information, feel free to let me know!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…